PELL Bio-Med Technology Co. Ltd. (6949.TW)

TWD 121.0

(-0.82%)

Total Liabilities Summary of PELL Bio-Med Technology Co. Ltd.

  • PELL Bio-Med Technology Co. Ltd.'s latest annual total liabilities in 2023 was 236.76 Million TWD , up 3.03% from previous year.
  • PELL Bio-Med Technology Co. Ltd.'s latest quarterly total liabilities in 2024 Q2 was 335 Million TWD , up 52.47% from previous quarter.
  • PELL Bio-Med Technology Co. Ltd. reported annual total liabilities of 229.79 Million TWD in 2022, up 35.96% from previous year.
  • PELL Bio-Med Technology Co. Ltd. reported annual total liabilities of 169.01 Million TWD in 2021, down 0.0% from previous year.
  • PELL Bio-Med Technology Co. Ltd. reported quarterly total liabilities of 335 Million TWD for 2024 Q2, up 52.47% from previous quarter.
  • PELL Bio-Med Technology Co. Ltd. reported quarterly total liabilities of 236.76 Million TWD for 2023 Q4, up 2.15% from previous quarter.

Annual Total Liabilities Chart of PELL Bio-Med Technology Co. Ltd. (2023 - 2021)

Created with Highcharts 11.1.0YearsTotal Liabilities20212021.22021.42021.62021.820222022.22022.42022.62022.82023160000000 TWD180000000 TWD200000000 TWD220000000 TWD240000000 TWD260000000 TWD

Historical Annual Total Liabilities of PELL Bio-Med Technology Co. Ltd. (2023 - 2021)

Year Total Liabilities Total Liabilities Growth
2023 236.76 Million TWD 3.03%
2022 229.79 Million TWD 35.96%
2021 169.01 Million TWD 0.0%

Peer Total Liabilities Comparison of PELL Bio-Med Technology Co. Ltd.

Name Total Liabilities Total Liabilities Difference
Apex Biotechnology Corp. 500.07 Million TWD 52.654%
Sinphar Pharmaceutical Co.,Ltd. 2.85 Billion TWD 91.702%
Panion & Bf Biotech Inc. 1.32 Billion TWD 82.119%
Chunghwa Chemical Synthesis & Biotech Co., Ltd. 1.82 Billion TWD 87.001%
GenMont Biotech Incorporation 204.05 Million TWD -16.028%
Abnova (Taiwan) Corporation 69.42 Million TWD -241.042%
Adimmune Corporation 3.7 Billion TWD 93.613%
Tanvex BioPharma, Inc. 1.94 Billion TWD 87.81%
Polaris Group 1.46 Billion TWD 83.836%
Energenesis Biomedical CO.,LTD. 24.58 Million TWD -862.968%
UnicoCell Biomed Co., Ltd. 89.48 Million TWD -164.58%